| Literature DB >> 32639862 |
Kurosh Parsi1,2, Andre M van Rij2, Mark H Meissner1,3,4, Alun H Davies5, Marianne De Maeseneer6, Peter Gloviczki7, Stephen Benson2, Oscar Bottini1, Victor Manuel Canata1, Paul Dinnen2, Antonios Gasparis3, Sergio Gianesini1, David Huber2, David Jenkins2, Brajesh K Lal3, Lowell Kabnick1, Adrian Lim2, William Marston3, Alberto Martinez Granados8, Nick Morrison1,4, Andrew Nicolaides9, Peter Paraskevas2, Malay Patel1, Stefania Roberts2, Christopher Rogan2,10, Marlin W Schul4, Pedro Komlos11, Andrew Stirling2, Simon Thibault2, Roy Varghese12, Harold J Welch3, Cees Ha Wittens13.
Abstract
The coronavirus disease 2019 (COVID-19) global pandemic has resulted in diversion of healthcare resources to the management of patients infected with SARS-CoV-2 virus. Elective interventions and surgical procedures in most countries have been postponed and operating room resources have been diverted to manage the pandemic. The Venous and Lymphatic Triage and Acuity Scale was developed to provide an international standard to rationalise and harmonise the management of patients with venous and lymphatic disorders or vascular anomalies. Triage urgency was determined based on clinical assessment of urgency with which a patient would require medical treatment or surgical intervention. Clinical conditions were classified into six categories of: (1) venous thromboembolism (VTE), (2) chronic venous disease, (3) vascular anomalies, (4) venous trauma, (5) venous compression and (6) lymphatic disease. Triage urgency was categorised into four groups and individual conditions were allocated to each class of triage. These included (1) medical emergencies (requiring immediate attendance), example massive pulmonary embolism; (2) urgent (to be seen as soon as possible), example deep vein thrombosis; (3) semi-urgent (to be attended to within 30-90 days), example highly symptomatic chronic venous disease, and (4) discretionary/non-urgent- (to be seen within 6-12 months), example chronic lymphoedema. Venous and Lymphatic Triage and Acuity Scale aims to standardise the triage of patients with venous and lymphatic disease or vascular anomalies by providing an international consensus-based classification of clinical categories and triage urgency. The scale may be used during pandemics such as the current COVID-19 crisis but may also be used as a general framework to classify urgency of the listed conditions.Entities:
Keywords: COVID-19; SARS-CoV-2; lymphatic; pandemic; triage; vascular; vascular anomalies; vascular malformations ; venous
Mesh:
Year: 2020 PMID: 32639862 PMCID: PMC7441329 DOI: 10.1177/0268355520930884
Source DB: PubMed Journal: Phlebology ISSN: 0268-3555 Impact factor: 1.740